Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation

Mostrar otras versiones (2)

Vaccine-induced neutralizing antibodies (nAbs) are key biomarkers considered to be associated with vaccine efficacy. In United States government-sponsored phase 3 efficacy trials of COVID-19 vaccines, nAbs are measured by two different validated pseudovirus-based SARS-CoV-2 neutralization assays, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yunda, Borisov, Oleg, Kee, Jia Jin, Carpp, Lindsay N., Wrin, Terri, Cai, Suqin, Sarzotti-Kelsoe, Marcella, McDanal, Charlene, Eaton, Amanda, Pajon, Rolando, Hural, John, Posavad, Christine M., Gill, Katherine, Karuna, Shelly, Corey, Lawrence, McElrath, M. Juliana, Gilbert, Peter B., Petropoulos, Christos J., Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671391/
https://www.ncbi.nlm.nih.gov/pubmed/34907214
http://dx.doi.org/10.1038/s41598-021-03154-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671391/
https://www.ncbi.nlm.nih.gov/pubmed/34907214
http://dx.doi.org/10.1038/s41598-021-03154-6

Ejemplares similares